Kanagawa, Japan

Ikuo Inage

This inventor holds 2 USPTO granted patents. Top assignee: Mitsui Toatsu Chemicals, Incorporated. Active years: 1988-1992.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 116(Granted Patents)


Location History:

  • Yokohama, JP (1988)
  • Kanagawa, JP (1992)

Company Filing History:


Years Active: 1988-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ikuo Inage: Innovator in Electrostrictive Technology

Introduction

Ikuo Inage is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of electrostrictive materials and medical devices. With a total of 2 patents, Inage's work showcases his innovative spirit and dedication to advancing technology.

Latest Patents

Inage's latest patents include a multi-layered electrostrictive effect element and a catheter equipped with a pressure sensor. The multi-layered electrostrictive effect element comprises films or thin plates of an electrostrictive material and inner electrodes arranged in layers. This design aims to enhance the dielectric strength of the element. The catheter with a pressure sensor is designed for insertion into blood vessels, featuring a fine insertion tube with sufficient stiffness and a flexible guide tube.

Career Highlights

Ikuo Inage is currently associated with Mitsui Toatsu Chemicals, Incorporated, where he continues to develop innovative solutions in his field. His work has been instrumental in pushing the boundaries of electrostrictive technology and its applications.

Collaborations

Inage has collaborated with notable coworkers, including Atsushi Hagimura and Mutsuo Nakajima. Their combined expertise has contributed to the successful development of advanced technologies.

Conclusion

Ikuo Inage's contributions to electrostrictive materials and medical devices highlight his role as a leading inventor in Japan. His innovative patents reflect a commitment to enhancing technology for practical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…